Analysis of the inheritance pattern of a Chinese family with phaeochromocytomas through whole exome sequencing

Gene

Volumn 526, Issue 2, 2013, Pages 164-169

  Cao, Min ^a   Sun, Fukang ^a   Huang, Xin ^a   Dai, Jun ^a   Cui, Bin ^a   Ning, Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Inheritance pattern; Phaeochromocytomas; Sanger sequencing; Whole exome sequencing

Indexed keywords

ARTICLE; CASE REPORT; CELL ADHESION; DOMINANT INHERITANCE; EXOME; FEMALE; GENETIC SUSCEPTIBILITY; HAPLOTYPE MAP; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INHERITANCE; MALE; PARAGANGLIOMA; PEDIGREE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RECESSIVE INHERITANCE; WHOLE EXOME SEQUENCING;

COMPUTED TOMOGRAPHY; COMPUTED TOMOGRAPHY ANGIOGRAPHY; CT; CTA; FALSE DISCOVERY RATE; FDR; GENE ONTOLOGY; GO; INDEL; INHERITANCE PATTERN; INSERTION-DELETION; LOD; LOGARITHM OF ODDS; MEN2; METANEPHRINE; MN; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2; NEUROFIBROMATOSIS TYPE 1; NF1; NMN; NON-SYNONYMOUS; NONPARAMETRIC LINKAGE; NORMETANEPHRINE; NPL; NS; PARAGANGLIOMAS; PCCS; PGLS; PHAEOCHROMOCYTOMAS; SANGER SEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE NUCLEOTIDE VARIATION; SNP; SNV; SPLICE SITE; SS; TARGET REGION; TR; VHL; VON HIPPEL-LINDAU; WHOLE EXOME SEQUENCING;

ADRENAL GLAND NEOPLASMS; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; EXOME; FEMALE; GERM CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INHERITANCE PATTERNS; MALE; PEDIGREE; PHENOTYPE; PHEOCHROMOCYTOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84880757760     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.04.081     Document Type: Article

References (34)

1. Abecasis G.R., Cherny S.S., Cookson W.O., Cardon L.R. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat. Genet. 2002, 30:97-101.
2. Adzhubei I.A., et al. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7:248-249.
3. Albert T.J., et al. Direct selection of human genomic loci by microarray hybridization. Nat. Methods 2007, 4:903-905.
4. Ashburner M., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25:25-29.
5. Bryant J., Farmer J., Kessler L.J., Townsend R.R., Nathanson K.L. Pheochromocytoma: the expanding genetic differential diagnosis. J. Natl. Cancer Inst. 2003, 95:1196-1204.
6. Buffet A., et al. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma. Horm. Metab. Res. 2012, 44:359-366.
7. Burnichon N., et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum. Mol. Genet. 2010, 19:3011-3020.
8. Burnichon N., et al. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum. Mol. Genet. 2011, 20:3974-3985.
9. Burnichon N., et al. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin. Cancer Res. 2012, 18:2828-2837.
10. Cascon A., et al. Genetics of pheochromocytoma and paraganglioma in Spanish patients. J. Clin. Endocrinol. Metab. 2009, 94:1701-1705.
11. Chrisoulidou A., Kaltsas G., Ilias I., Grossman A.B. The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr. Relat. Cancer 2007, 14:569-585.
12. Dahia P.L., et al. Novel pheochromocytoma susceptibility loci identified by integrative genomics. Cancer Res. 2005, 65:9651-9658.
13. Gimenez-Roqueplo A.P., et al. Phaeochromocytoma, new genes and screening strategies. Clin. Endocrinol. (Oxf.) 2006, 65:699-705.
14. Gimenez-Roqueplo A.P., Dahia P.L., Robledo M. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm. Metab. Res. 2012, 44:328-333.
15. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
16. Jafri M., Maher E.R. The genetics of phaeochromocytoma: using clinical features to guide genetic testing. Eur. J. Endocrinol. 2012, 166:151-158.
17. Jensen L.J., et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 2009, 37:D412-D416.
18. Kantorovich V., King K.S., Pacak K. SDH-related pheochromocytoma and paraganglioma. Best Pract. Res. Clin. Endocrinol. Metab. 2010, 24:415-424.
19. Kong A., Cox N.J. Allele-sharing models: LOD scores and accurate linkage tests. Am. J. Hum. Genet. 1997, 61:1179-1188.
20. Lenders J.W., Eisenhofer G., Mannelli M., Pacak K. Phaeochromocytoma. Lancet 2005, 366:665-675.
21. Li R., et al. SNP detection for massively parallel whole-genome resequencing. Genome Res. 2009, 19:1124-1132.
22. Li R., et al. SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 2009, 25:1966-1967.
23. Mazzaglia P.J. Hereditary pheochromocytoma and paraganglioma. J. Surg. Oncol. 2012.
24. Mittendorf E.A., Evans D.B., Lee J.E., Perrier N.D. Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment. Hematol. Oncol. Clin. North Am. 2007, 21:509-525. (ix).
25. Morton N.E. Sequential tests for the detection of linkage. Am. J. Hum. Genet. 1955, 7:277-318.
26. Neumann H.P., et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004, 292:943-951.
27. Ng P.C., Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003, 31:3812-3814.
28. Ng S.B., et al. Exome sequencing identifies the cause of a Mendelian disorder. Nat. Genet. 2010, 42:30-35.
29. Prasad R., et al. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res. 1993, 53:5624-5628.
30. Purcell S., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
31. Qin Y., et al. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat. Genet. 2010, 42:229-233.
32. Taya S., et al. The Ras target AF-6 is a substrate of the fam deubiquitinating enzyme. J. Cell Biol. 1998, 142:1053-1062.
33. Wang Y., et al. Exome sequencing identifies compound heterozygous mutations in CYP4V2 in a pedigree with retinitis pigmentosa. PLoS One 2012, 7:e33673.
34. Welander J., Soderkvist P., Gimm O. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr. Relat. Cancer 2011, 18:R253-R276.